Trademark Overview
On Friday, July 18, 2025, a trademark application was filed for EYGEXO with the United States Patent and Trademark Office. The USPTO has given the EYGEXO trademark a serial number of 99289264. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, January 7, 2026. This trademark is owned by Beacon Therapeutics Limited. The EYGEXO trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical apparatus and instruments for treating eye diseases and conditions; medical apparatus and instruments used in the treatment of ocular disorders; Medical apparatus and instruments for introducing pharmaceutical preparations into the human body; Medical apparatus and instruments for the injection of pharmaceutical preparations; Medical apparatus and instruments for introducing pharmaceutical preparations into the human body, for use in gene therapy and cell therapy
Pharmaceutical preparations and substances for the treatment of eye diseases and conditions; Pharmaceutical preparations for gene therapy and cell therapy for the treatment of eye diseases and conditions; Pharmaceutical preparations and substances for the treatment of ocular disorders; Biotechnological pharmaceutical preparations for the treatment of ocular disorders; Pharmaceutical preparations for gene therapy and cell therapy for the treatment of ocular disorders; genetic medicines for the treatment of ocular disorders
Medical treatment services in the field of eye diseases and conditions; Provision of medical information and services; Medical information provided to patients and healthcare professionals concerning pharmaceutical products, preparations for gene therapy and cell therapy, medical diseases and disorders and related treatments; Medical treatment services in the field of ocular disorders; Provision of medical information and services in the field of ocular disorders